Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-16-137735
Filing Date
2016-12-02
Accepted
2016-12-02 17:02:29
Documents
1
Period of Report
2016-11-30

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT v454259_4.html 4  
1 OWNERSHIP DOCUMENT v454259_4.xml 4 3969
  Complete submission text file 0001144204-16-137735.txt   5787
Mailing Address 155 GIBBS STREET SUITE 412 ROCKVILLE MD 20850
Business Address 617 DETROIT STREET, SUITE 100 ANN ARBOR MI 48104 (734) 332-7800
Synthetic Biologics, Inc. (Issuer) CIK: 0000894158 (see all company filings)

EIN.: 133808303 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 20425 SENECA MEADOWS PARKWAY GERMANTOWN MD 20876
Business Address 20425 SENECA MEADOWS PARKWAY GERMANTOWN MD 20876 301 944 6600
SHALLCROSS STEVEN A (Reporting) CIK: 0001263501 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-12584 | Film No.: 162031820